SecBot SecBot
PRESS-RELEASE ·Filed Apr 16, 2026

EBS

Emergent BioSolutions
BEARISH
Impact 7/10
Horizonweeks Processed7mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▼ Bearish

The refinancing provides near-term stability, but the 72% EPS miss raises concerns about the pace of turnaround. Traders should monitor whether cost savings translate into future margin improvement or if fundamental challenges persist.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$8.81
T+0 close · Apr 16, 2026 · via day close
Latest settled
−14.87%
T+60 · $7.50
Vs SPY
−21.01%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 17 $8.81entry
  2. T+1 · 7mo ago −5.22%α −5.03% · $8.35
  3. T+5 · 7mo ago −8.85%α −9.41% · $8.03
  4. T+20 · 6mo ago −6.81%α −12.18% · $8.21
  5. T+60 · 4mo ago −14.87%α −21.01% · $7.50
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Emergent BioSolutions announced a $150 million term loan refinancing with OrbiMed and an amended $50 million ABL facility, extending maturities to April 2031 and reducing interest expense by 200 basis points. The move strengthens liquidity but follows a significant earnings miss.

Key Financial Metrics

EPS
−$0.43
est −$0.25 · -72.0%
Revenue
$160.5M
est $160.5M · 0.0%
Rating
strong miss

Key Facts

  • Closed on a new $150 million term loan with OrbiMed, replacing prior debt from Oak Hill Advisors
  • Amended ABL facility with Wells Fargo to extend borrowing capacity of $50 million through April 2031
  • Interest expense reduced by 200 basis points annually
  • Maturities extended from 2029 to 2031 for both facilities
  • EPS of $-0.43 missed consensus of $-0.25 by 72%, indicating significant deterioration in profitability

Financial Impact

Interest expense reduction of 200 bps improves cash flow; however, $160.5M revenue and $-0.43 EPS reflect ongoing operational weakness

debtinterest expenseepscashFlow

Risk Factors

  • Continued negative earnings trajectory despite balance sheet improvements
  • Forward-looking statements about capital deployment carry high uncertainty
  • Limited revenue visibility amid transformation plan

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3275807

Track record

23 reports on EBS

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +14.89% at T+20 after the Apr 29, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $5.76 Now $5.81 +0.96% settles Nov 23
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.75 Now $5.81 +1.13% settles Nov 23
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.79 Now $5.81 +0.35% settles Nov 23
  4. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $5.85 to $5.89 Now $5.81 −0.68% ▲ +0.68% −2.61% vs SPY
  5. Nov 2, 202614d ago 8-K Bearish 6/10 Entry $6.25 to $6.05 Now $5.81 +7.04% ▲ +3.20% +2.61% vs SPY
  6. Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $6.81 to $6.06 Now $5.81 −14.68% ▼ −11.01% −8.31% vs SPY
  7. Oct 16, 20264w ago 8-K Neutral 3/10 Entry $6.38 to $6.23 Now $5.81 −8.93% ▼ −2.35% −2.44% vs SPY
  8. Oct 7, 20265w ago 144 Neutral 2/10 Entry $6.81 to $7.18 Now $5.81 −14.68% ▲ +5.43% +5.71% vs SPY
  9. Jun 29, 202620w ago 8-K Bullish 5/10 Entry $8.46 to $8.18 Now $5.81 −31.32% ▼ −3.31% −4.70% vs SPY
  10. Jun 4, 202623w ago Press Release Neutral 2/10 Entry $8.44 to $8.39 Now $5.81 −31.16% ▼ −0.59% +1.96% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 16, 2026